WDR 2026 | Data Portal UNODC

Skip to main content

User account menu

Log in

Data Portal UNODC

World Drug Report 2026

Start Page
Search
WDR Home
Statistical Annex

Browse

Drug supply

Cultivation

Illicit Crop Cultivation

Seizures

Global Seizures Long-Term Seizure Trends Modes of transport

Dark Web

What is the Dark Web? Dark Web Sales Dark Web Markets

ATS

Overview

Supply

Global Market Global Seizures Seizures in Europe

Demand

Global Demand Demand in Europe Treatment in East and South-East Asia Recent trends in Central Asia, Transcaucasia and Eastern Europe

Amphetamine

Supply

Global Seizures Near and Middle East

Methamphetamine

Supply

Global Seizures Trafficking Routes Precursors North America Asia East and South-East Asia Near and Middle East / South-West Asia Australia and New Zealand

Demand

North America Australia and New Zealand (use) Australia and New Zealand (harm)

"Ecstasy"

Supply

Global Seizures Precursors Trafficking

Demand

Global Demand Europe Australia and New Zealand

Cannabis

Supply

Overview

Global Overview

Production process

Global Cultivation Cultivation Methods and Potency

Seizures

Global Seizures Cannabis Herb Seizures Cannabis Resin Seizures

Demand

Global

Global Demand Use and Treatment

Africa

Americas

South and Central America

Europe

Europe (use) Europe (harm)

Oceania

Australia and New Zealand

New developments

Semi-Synthetic Cannabinoids

Cocaine

Overview

Supply

Coca Bush Cultivation Cultivation Trends Seizures Trafficking Flows Manufacture and seizures Global market Purities

Demand

Global Demand Demand by Region Americas Americas Europe Europe Australia and New Zealand

Emerging Markets

Seizures Africa Asia

Opioids

Overview

Supply

Main illicit opium producing countries Opium production and prices Opiate Seizures Opiate Trafficking Flows Seizures of Pharmaceutical Opioids (global) Seizures of Pharmaceutical Opioids (S-DDDs)

Demand

Opioid Demand Opioid use trends Opiate use trends North America Asia Europe Non-Medical Use of Tramadol

Emerging Threats

Nitazenes and Orphines

NPS

Overview

Supply

NPS Identified Seizures of Synthetic NPS Seizures of Plant-Based NPS

Demand

Global Demand Demand among youth Demand among youth (trends)

Ketamine

Ketamine Seizures Ketamine Use

Synthetic drugs

Synthetic drugs in relation to plant-based

Drug use & health consequences

Drug use

Global Demand Global Demand by Type Trends in Demand Synthetic Drug Use Stimulant Drug Use Drug Use and Age Drug Use Among Special Groups

Polydrug use

Use Patterns Use Patterns Among People in Treament Polydrug-Related Deaths Mixtures and Blends

People Who Inject Drugs

PWID PWID living with HIV PWID living with Hepatitis B/C

Drug-Related Harm

Harm by Drug Drug-Related Deaths Years of Healthy Life Lost (DALYs)

Treatment

Introduction Referrals and Interventions Treatment Access Coverage of Interventions (SDG 3.5.1) Socioeconomic characteristics of patients Primary Drug of Use By Drug, Region and Sex Age Distribution Use and Treatment by Sex

Policy

Cannabis Legislation

Legislation in Selected Countries

Opioids for Medical Use

Availability Availability by Region Availability by Type Opioids used in substitution treatment

Criminal Justice Response

Legal Framework Estimates By Sex Severity of Sentencing

Methodological Annex

ATS>>Overview>>Supply

ATS – Scale of the market

ATS seizures reached a new record high in 2024, dominated by methamphetamine.

Download Dataset

Pagination

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
…
Next page
Last page

Browse by keyword

A

ASEAN

Treatment in East and South-East Asia

ATS

Methamphetamine – global seizures Methamphetamine precursors and laboratories

Age group

15-16

NPS use among young people - Prevalence NPS use among young people - Trends

18-24

Age profile of people in drug treatment

25-34

Age profile of people in drug treatment

35-64

Age profile of people in drug treatment

65 And Above

Age profile of people in drug treatment

Age profile of people in drug treatment

Aging

Age profile of people in drug treatment

All clients in drug treatment

Opioids use and associated harm in Europe

Americas

Long-term trends in cocaine use and related treatment

Amphetamine

Australia and New Zealand (harm) Australia and New Zealand (use) Consumer markets for amphetamines Global magnitude of use of different drugs Methamphetamine – global seizures Methamphetamine precursors and laboratories Most used stimulant drug by country Recent trends in global drug use

Amphetamine-type stimulants

Australia and New Zealand (harm) Australia and New Zealand (use) Amphetamines use in Europe Direct drug-related deaths Consumer markets for amphetamines Patterns of drug-related disorders, treatment and deaths Harms caused by methamphetamine use in North America Primary drug of use of people in drug treatment by country Treatment in East and South-East Asia

Annual prevalence

NPS use among young people - Prevalence NPS use among young people - Trends

Arrests

Cocaine use and associated harm in Australia and New Zealand Scale of the cocaine market in 2024

Asia

Long-term trends in cocaine use and related treatment Non-medical use of tramadol

Australia

Ecstasy use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Australia and New Zealand (harm) Australia and New Zealand (use) Scale of the cocaine market in 2024

B

Below 18

Age profile of people in drug treatment

Benzoylecgonine

Cocaine use in South America Regional breakdown of cocaine use Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets

C

"Crack" cocaine

Cocaine use in South America Cocaine use and associated harm in North America Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets

Canada

Harms caused by methamphetamine use in North America

Cannabis

Cannabis use and treatment in Africa Cannabis use in Australia and New Zealand Drug use and age Direct drug-related deaths Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Geographical distribution of and long-term trends in cannabis use Global magnitude of use of different drugs Cannabis Overview Patterns of drug-related disorders, treatment and deaths Trends in global seizures Primary drug of use of people in drug treatment by country Synthetic drug use by country Recent trends in global drug use Regional trends in cannabis use and treatment

Cannabis harm

Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Cannabis-related treatment

Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

China

East and South-East Asia and South Asia

Clear Web

What is the dark web?

Coca

Trends in global seizures

Cocaine

Cocaine use in South America Cocaine use and associated harm in North America Cocaine use and associated harm in Australia and New Zealand Regional breakdown of cocaine use Direct drug-related deaths Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets Long-term trends in cocaine use and related treatment Global magnitude of use of different drugs Scale of the cocaine market in 2024 Patterns of drug-related disorders, treatment and deaths Trends in global seizures Primary drug of use of people in drug treatment by country Most used stimulant drug by country Recent trends in global drug use

Cocaine base paste

Cocaine use in South America

Cocaine products

Cocaine use in South America

Cocaine salts

Cocaine use in South America

Cocaine-type drugs

Cocaine use in South America

Codeine

Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Coverage

SDG 3.5.1 Treatment coverage

Cultivation

Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

D

DALYs

Global estimates of total drug-related harm - deaths and DALYs

DMT

Prevalence of NPS use

Daily or near-daily cannabis use

Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Dark Web

Darknet markets Darknet sales What is the dark web?

Darknet

What is the dark web?

Darknet markets

Darknet markets Darknet sales

Deep Web

What is the dark web?

Demand

Cocaine use and associated harm in North America Australia and New Zealand (harm) Australia and New Zealand (use) Regional breakdown of cocaine use Amphetamines use in Europe Cocaine use in Europe – current snapshot

Direct drug-related deaths

Direct drug-related deaths Non-medical use of tramadol Harms caused by methamphetamine use in North America

Drug Treatment

Australia and New Zealand (harm) Australia and New Zealand (use)

Drug treatment

Cannabis use and treatment in Africa East and South-East Asia and South Asia Opioids use and associated harm in Europe Non-medical use of tramadol Harms caused by methamphetamine use in North America Regional trends in cannabis use and treatment

Drug use

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

Drug use disorders

Patterns of drug-related disorders, treatment and deaths

Drug use in the past year

Drug use and treatment by sex

Drug-related mortality

Cocaine use in South America Cocaine use and associated harm in Australia and New Zealand Direct drug-related deaths Long-term trends in cocaine use and related treatment Scale of the cocaine market in 2024 Patterns of drug-related disorders, treatment and deaths Harm associated with opioid use in North America Global estimates of total drug-related harm - deaths and DALYs

Drug-related treatment

Age profile of people in drug treatment Cocaine use and associated harm in Australia and New Zealand SDG 3.5.1 Treatment coverage Amphetamines use in Europe Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets Long-term trends in cocaine use and related treatment Scale of the cocaine market in 2024 Patterns of drug-related disorders, treatment and deaths Primary drug of use of people in drug treatment by country Drug use and treatment by sex

E

"Ecstasy" forms

Ecstasy use in Australia and New Zealand

"Ecstasy"-type substances

Ecstasy use in Australia and New Zealand Direct drug-related deaths Ecstasy use by region Global magnitude of use of different drugs Methamphetamine – global seizures Methamphetamine precursors and laboratories Most used stimulant drug by country Recent trends in global drug use

EDRS

Ecstasy use in Australia and New Zealand Australia and New Zealand (harm) Australia and New Zealand (use)

East and South-East Asia

East and South-East Asia and South Asia

Eastern Europe

Opioids use and associated harm in Europe

Eastern and South-Eastern Europe

Long-term trends in cocaine use and related treatment

Estimated number of past-year users

Recent trends in global drug use

Estimated number of users

Cannabis use in Australia and New Zealand Ecstasy use by region Cannabis Overview

Estimates

Geographical distribution of and long-term trends in cannabis use Global and regional trends in opiate use Global and regional trends in opioid use

Europe

Opioids use and associated harm in Europe Non-medical use of tramadol

Expert assessment of trend

Cannabis use in Australia and New Zealand Cannabis Overview

F

Fatal overdoses

Cocaine use and associated harm in North America Harm associated with opioid use in North America

Fatal poisonings

Non-medical use of tramadol

Females / women

Cocaine use and associated harm in Australia and New Zealand SDG 3.5.1 Treatment coverage Drug use and age Cocaine use in Europe – current snapshot Scale of the cocaine market in 2024 Drug use and treatment by sex

Fentanyl

Global Opium Cultivation and Production Harm associated with opioid use in North America Opium production and opiate seizures Distribution of seizures Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

First-time treated

Opioids use and associated harm in Europe

G

Gender

Drug use and age

General population

Prevalence of NPS use

General population survey

Cocaine use in South America Cocaine use and associated harm in North America Ecstasy use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Cocaine use in Europe – current snapshot Consumer markets for amphetamines Geographical distribution of and long-term trends in cannabis use Prevalence of NPS use Scale of the cocaine market in 2024 Drug use and treatment by sex

Global

The criminal justice process by sex People in contact with the criminal justice system Geographical distribution of and long-term trends in cannabis use Global magnitude of drug use Global magnitude of use of different drugs Legislating drug offences Global and regional trends in opiate use Global and regional trends in opioid use Severity of sentencing for criminalized drug offences

Global Burden of Disease study

Global estimates of total drug-related harm - deaths and DALYs

Global estimates

Cannabis use in Australia and New Zealand Drug use and age Global magnitude of drug use Global magnitude of use of different drugs Cannabis Overview

H

HBV

People who inject drugs living with hepatitis

HBV among people who inject drugs

People who inject drugs living with hepatitis

HIV among people who inject drugs

People who inject drugs living with HIV

HIV/AIDS

People who inject drugs living with HIV

Hallucinogens

Direct drug-related deaths Primary drug of use of people in drug treatment by country

Harmful use of substance

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

Harms

Cocaine use and associated harm in Australia and New Zealand Cocaine in Europe – trends in use, harms and domestic markets Scale of the cocaine market in 2024

Hepatitis B

People who inject drugs living with hepatitis

Hepatitis C

People who inject drugs living with hepatitis

Heroin

East and South-East Asia and South Asia Global Opium Cultivation and Production Harm associated with opioid use in North America Opium production and opiate seizures Distribution of seizures Global and regional trends in opiate use Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Hospitalizations

Cocaine use and associated harm in Australia and New Zealand Scale of the cocaine market in 2024 Harms caused by methamphetamine use in North America

Household survey

Cocaine use in South America Cocaine use and associated harm in North America Ecstasy use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Cocaine use in Europe – current snapshot Consumer markets for amphetamines Geographical distribution of and long-term trends in cannabis use Prevalence of NPS use Scale of the cocaine market in 2024 Drug use and treatment by sex

I

IDRS

Australia and New Zealand (harm) Australia and New Zealand (use)

Injecting Drug Use

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

Internet

Darknet markets Darknet sales What is the dark web?

K

Ketamine

NPS use among young people - Prevalence NPS use among young people - Trends Prevalence of NPS use Ketamine trafficking and seizures

Key population

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

Kratom

Prevalence of NPS use

L

Long-term trends

Cannabis use in Australia and New Zealand Long-term trends in cocaine use and related treatment Cannabis Overview Treatment in East and South-East Asia

M

MDMA

Ecstasy use in Australia and New Zealand "Ecstasy" use in Europe Ecstasy use by region Overview: ATS seizures and dismantled laboratories

MDMA capsules

Ecstasy use in Australia and New Zealand

MDMA crystal

Ecstasy use in Australia and New Zealand

MDMA pills

Ecstasy use in Australia and New Zealand

MDMA powder

Ecstasy use in Australia and New Zealand

Male to female ratio

Cocaine use in Europe – current snapshot

Males / men

Cocaine use and associated harm in Australia and New Zealand SDG 3.5.1 Treatment coverage Drug use and age Cocaine use in Europe – current snapshot Scale of the cocaine market in 2024 Drug use and treatment by sex

Mean loads per 1,000 inhabitants

Ecstasy use by region

Measures of harm

Patterns of drug-related disorders, treatment and deaths

Mephedrone

NPS use among young people - Prevalence NPS use among young people - Trends Prevalence of NPS use

Methamphetamine

Australia and New Zealand (harm) Australia and New Zealand (use) Consumer markets for amphetamines Methamphetamine – global seizures Harms caused by methamphetamine use in North America Methamphetamine precursors and laboratories Most used stimulant drug by country Treatment in East and South-East Asia

Mexico

Harms caused by methamphetamine use in North America

Minimum sales

Darknet markets Darknet sales

Morphine

Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Mortality

Global estimates of total drug-related harm - deaths and DALYs

N

NPS appearance

NPS use among young people - Prevalence NPS use among young people - Trends

Never previously treated

Opioids use and associated harm in Europe

New Zealand

Ecstasy use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Scale of the cocaine market in 2024

New clients in drug treatment

Opioids use and associated harm in Europe

New psychoactive substances

NPS use among young people - Prevalence NPS use among young people - Trends Direct drug-related deaths Prevalence of NPS use Non-medical use of tramadol Primary drug of use of people in drug treatment by country

Non-medical use

Non-medical use of tramadol

Non-medical use of pharmaceutical products containing amphetamine-type stimulants

Most used stimulant drug by country

North America

Cocaine use and associated harm in North America Harms caused by methamphetamine use in North America

Number of people

Consumer markets for amphetamines

Number of people who inject drugs living with HIV

People who inject drugs living with HIV

Number of people who inject drugs living with hepatitis B

People who inject drugs living with hepatitis

Number of people who use drugs

Global magnitude of drug use Global magnitude of use of different drugs

Number of people who use opiates

Global and regional trends in opiate use

Number of people who use opioids

Global and regional trends in opioid use

Number of users

Cannabis use in Australia and New Zealand Geographical distribution of and long-term trends in cannabis use Cannabis Overview

O

Oceania

Cocaine use and associated harm in Australia and New Zealand Australia and New Zealand (harm) Australia and New Zealand (use) Scale of the cocaine market in 2024

Opiates

Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Global and regional trends in opiate use Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Opioids

East and South-East Asia and South Asia Direct drug-related deaths Opioids use and associated harm in Europe Global magnitude of use of different drugs Global Opium Cultivation and Production Patterns of drug-related disorders, treatment and deaths Non-medical use of tramadol Harm associated with opioid use in North America Opium production and opiate seizures Distribution of seizures Opioids - introduction and regional breakdown Global and regional trends in opioid use Opium production and prices Primary drug of use of people in drug treatment by country Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview Recent trends in global drug use

Opium

Global Opium Cultivation and Production Trends in global seizures Opium production and opiate seizures Distribution of seizures Global and regional trends in opiate use Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Other drugs

Primary drug of use of people in drug treatment by country

Overdose deaths

Non-medical use of tramadol

P

PWID

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

Past-year use

Drug use and age

People who inject drugs

People who inject drugs People who inject drugs living with HIV People who inject drugs living with hepatitis

People who use amphetamines

Consumer markets for amphetamines

Perceived availability

Cocaine use and associated harm in Australia and New Zealand Scale of the cocaine market in 2024

Pharmaceutical opioids

Global Opium Cultivation and Production Harm associated with opioid use in North America Opium production and opiate seizures Distribution of seizures Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Pharmaceutical sedatives and tranquilizers

Direct drug-related deaths

Prevalence of HBV among PWID

People who inject drugs living with hepatitis

Prevalence of HIV among PWID

People who inject drugs living with HIV

Prevalence of drug use

NPS use among young people - Prevalence NPS use among young people - Trends Regional breakdown of cocaine use Consumer markets for amphetamines Ecstasy use by region Geographical distribution of and long-term trends in cannabis use Global magnitude of drug use Prevalence of NPS use Global magnitude of use of different drugs Global and regional trends in opiate use Opioids - introduction and regional breakdown Global and regional trends in opioid use Drug use and treatment by sex

Prevalence of use

Cocaine use in South America

Price

Cocaine in Europe – trends in use, harms and domestic markets Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview Synthetic drug use by country

Primary drug

Cannabis use and treatment in Africa Opioids use and associated harm in Europe Primary drug of use of people in drug treatment by country Regional trends in cannabis use and treatment

Production

Global Opium Cultivation and Production Opium production and opiate seizures Distribution of seizures Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Projected sales

Darknet markets

Proportion

East and South-East Asia and South Asia

Purity

Cocaine in Europe – trends in use, harms and domestic markets Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Q

Qualitative assessment

Recent trends in global drug use

Qualitative information

Cannabis use in Australia and New Zealand Cannabis Overview

R

Regional

Consumer markets for amphetamines Geographical distribution of and long-term trends in cannabis use

Regional patterns

Regional breakdown of cocaine use

Regions

Global and regional trends in opiate use Global and regional trends in opioid use

Registry of drug users

East and South-East Asia and South Asia

Regular "Ecstasy" Users

Ecstasy use in Australia and New Zealand Australia and New Zealand (harm) Australia and New Zealand (use)

S

School survey

Cocaine use in South America NPS use among young people - Prevalence NPS use among young people - Trends Cocaine use in Europe – current snapshot

Sedatives and tranquilizers

Patterns of drug-related disorders, treatment and deaths

Sedatives and tranquilizers (non-medical use)

Primary drug of use of people in drug treatment by country

Seizures

Global Opium Cultivation and Production Methamphetamine – global seizures Ketamine trafficking and seizures Trends in global seizures Non-medical use of tramadol Opium production and opiate seizures Distribution of seizures Opium production and prices Methamphetamine precursors and laboratories Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Sewage epidemiology

Regional breakdown of cocaine use Amphetamines use in Europe "Ecstasy" use in Europe Ecstasy use by region Overview: ATS seizures and dismantled laboratories

Sex

Drug use and age Drug use and treatment by sex

Solvents and inhalants

Direct drug-related deaths Primary drug of use of people in drug treatment by country

South America

Cocaine use in South America

South-Eastern Europe

Amphetamines use in Europe Opioids use and associated harm in Europe Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Special surveys

Prevalence of NPS use

Stimulant

Most used stimulant drug by country

Sub-regional

Consumer markets for amphetamines Geographical distribution of and long-term trends in cannabis use

Subregions

Global and regional trends in opiate use Global and regional trends in opioid use

Substances

1P-LSD

Prevalence of NPS use

2C-B

Prevalence of NPS use

Sustainable Development Goals

SDG 3.5.1 Treatment coverage

Synthetic cannabinoid receptor agonists

NPS use among young people - Prevalence NPS use among young people - Trends Prevalence of NPS use

Synthetic cannabinoids

NPS use among young people - Prevalence NPS use among young people - Trends Prevalence of NPS use

Synthetic cathinones

Most used stimulant drug by country

Synthetic opioids

Harm associated with opioid use in North America

T

THC-COOH

Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Toxicological findings in drug-related deaths

Direct drug-related deaths

Tramadol

Global Opium Cultivation and Production Non-medical use of tramadol Opium production and opiate seizures Distribution of seizures Opioids - introduction and regional breakdown Opium production and prices Geographical patterns of seizures of key pharmaceutical opioids Pharmaceutical drugs – overview

Treatment episodes

Australia and New Zealand (harm) Australia and New Zealand (use) Harms caused by methamphetamine use in North America

Trends

Cannabis use and treatment in Africa Cocaine use in South America Cocaine use and associated harm in North America East and South-East Asia and South Asia Ecstasy use in Australia and New Zealand Cannabis use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Australia and New Zealand (harm) Australia and New Zealand (use) Amphetamines use in Europe Direct drug-related deaths "Ecstasy" use in Europe Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets Opioids use and associated harm in Europe Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Global magnitude of drug use Scale of the cocaine market in 2024 Cannabis Overview Overview: ATS seizures and dismantled laboratories Harm associated with opioid use in North America Global and regional trends in opiate use Global and regional trends in opioid use Synthetic drug use by country Recent trends in global drug use Regional trends in cannabis use and treatment

U

USA

Harms caused by methamphetamine use in North America

Use / Consumption

Cannabis use and treatment in Africa Regional trends in cannabis use and treatment

Use in lifetime

NPS use among young people - Prevalence NPS use among young people - Trends

Use in the past 12 months

NPS use among young people - Prevalence NPS use among young people - Trends

W

Wastewater analysis

Cocaine use in South America Ecstasy use in Australia and New Zealand Cocaine use and associated harm in Australia and New Zealand Regional breakdown of cocaine use Amphetamines use in Europe "Ecstasy" use in Europe Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets Ecstasy use by region Scale of the cocaine market in 2024 Overview: ATS seizures and dismantled laboratories

Wastewater epidemiology

Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Synthetic drug use by country

Western Africa

Non-medical use of tramadol

Western and Central Europe

Amphetamines use in Europe Cocaine use in Europe – current snapshot Cocaine in Europe – trends in use, harms and domestic markets Opioids use and associated harm in Europe Europe (harm) Trends in cannabis use in South-Eastern and Western and Central Europe Long-term trends in cocaine use and related treatment Synthetic drug use by country

Y

Youth

Age profile of people in drug treatment Australia and New Zealand (harm) Australia and New Zealand (use)

United Nations Copyright © 2025 UNODC - Data Portal

Access policy | Copyright | Fraud Alert | Privacy Notice | Terms and Conditions